Personalized Indications for CBT and Antidepressants in Treating Depression
Researchers are comparing cognitive behavioural therapy and Pharmacotherapy to find out how the approaches affect depression symptoms in people with depression.
Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers are comparing cognitive behavioural therapy and Pharmacotherapy to find out how the approaches affect depression symptoms in people with depression.
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
Read the official source — NCT07176468Efficacy of Personalized iTBS in Real-World Clinical Settings for Alleviating Schizophrenia Symptoms : A Randomized Single-Blind Trial
Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial
Read the official source — NCT07146802Towards a Personalized Medicine Approach to Psychological Treatment for Psychosis
Personalized Mobile Cognitive Behavioral Therapy Application
Read the official source — NCT05699525Efficacy of Personalized Mobile Cognitive Behavioral Therapy Targeting Anxiety and Depression
Personalized Pharmacotherapy Using Pharmacogenetics in Veterans
Read the official source — NCT06335043Personalized Pharmacotherapy Using Pharmacogenetics in Veterans Seeking Treatment for Mental Health
PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE
Read the official source — NCT07268768Personological Structure, Cognitive Functions and Central Sensitization in Headache: Obstacles and Resources in the Treatment of Chronic and Episodic Headache.
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
Read the official source — NCT04582916PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
Read the official source — NCT06795581PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
Read the official source — NCT07095205Central Cholinergic Dysfunction in Depression: PET Imaging of a Novel Treatment Target With [18F]VAT to Assess the Antidepressant Effect of Nicotine
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Read the official source — NCT05181891Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy
Read the official source — NCT04507555Pharmacist Guided Pre-emptive Pharmacogenetic Testing in Antidepressant Therapy
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
Read the official source — NCT05232032Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.